Pharmacokinetics alterations of midazolam infusion versus bolus administration in mechanically ventilated critically Ill patients

Iranian Journal of Pharmaceutical Research

Volumn 12, Issue 2, 2013, Pages 483-488

  Beigmohammadi, Mohammad Taghi ^a   Hanifeh, Majid ^b   Rouini, Mohammad Reza ^c   Sheikholeslami, Behjat ^c   Mojtahedzadeh, Mojtaba ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Continuous infusion; Intermittent bolus doses; Mechanical ventilation; Midazolam; Pharmacokinetics

Indexed keywords

MIDAZOLAM; MORPHINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CRITICALLY ILL PATIENT; DISTRIBUTION VOLUME; DRUG CLEARANCE; DRUG HALF LIFE; DRUG INTERMITTENT THERAPY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; PAIN; PROSPECTIVE STUDY; VENTILATED PATIENT;

EID: 84878910092     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Kress JP, Pohlman AS and Hall JB. Sedation and analgesia in the intensive care unit. Am. J. Respir. Crit. Care Med. (2002) 166: 1024-1028.
2. Jackson DL, Proudfoot CW, Cann KF and Walsh T. A systematic review of the impact of sedation practice in the ICU on resource use, costs and patient safety. J. Crit. Care. (2010) 14: R59.
3. Spina SP and Ensom MHH. Clinical pharmacokinetic monitoring of midazolam in critically ill patients. Pharmacotherapy (2007) 27: 389-398.
4. Fragen RJ. Pharmacokinetics and pharmacodynamics of midazolam given via continuous intravenous infusion in intensive care units. Clin. Ther. (1997) 19: 405-419.
5. Power BM, Forbes AM, Van Heerden PV and Ilett KF. Pharmacokinetics of drugs used in critically ill adults. Clin. Pharmacokinet. (1998) 34: 25-56.
6. Wagner BKJ and Ohara DA. Pharmacokinetics and pharmacodynamics of sedatives and analgesics in the treatment of agitated critically ill patients. Clin. Pharmacokinet. (1997) 33: 426-453.
7. Kress JP, Pohlman AS, Óconnor MF and Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N. Eng. J. Med. (2011) 342: 1471-1477.
8. Szokol JW and Vender JS. Anxiety, delirium, and pain in the intensive care unit. Crit. Care Clin. (2001) 17: 821-842.
9. Kollef MH, Levy NT, Ahrens TS, Schaiff R, Prentice D and Sherman G. The use of continuous IV sedation is associated with prolongation of mechanical ventilation. Chest. (1998) 114: 541-548.
10. Schweickert WD and Kress JP. Strategies to optimize analgesia and sedation. Crit. Care (2008) (Suppl 3): S6.
11. Acrangeli A, Antonelli M, Mignani V and Sandroni C. Sedation in PACU: the role of benzodiazepines. Curr. Drug. Targets. (2005) 6: 745-8.
12. Oldenhof H, De Jong M, Steenhock A and Janknegt R. Clinical pharmacokinetics of midazolam in intensive care patients, a wide interpatient variability? Clin. Pharmacol. Ther. (1988) 43: 263-9.
13. Malacrida R, Fritz ME, Suter PM and Crevosier C. Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care patients. Crit. Care Med. (1991) 20: 1123-1126.
14. Swart EL, Zuideveld KP, De Jongh J, Danhof M, Thijs LG and Van Schijndel RMJS. Comparative population pharmacokinetiscs of lorazepam and midazolam during long term continuous infusionin critically ill patients. Br. J. Clin. Pharmacol. (2003) 57: 135-145.
15. Perkins MW, Dasta JF and Deltaven B. Physiologic implications of mechanical ventilation on pharmacokinetics. DICP. (1989) 23: 316-323.
16. Richard C, Berdeaux A, Delion F, Riou B, Rimailho A, Giudicelli JF and Auzepy P. Effect of Mechanical Ventilation on Hepatic Drug Pharmacokinetics. Chest. (2011) 90: 837-841.
17. Hadavand N, Mojtahedzadeh M, Sadray S, Shariat Moharreri R, Shafaghi B, Khajavi MR and Salari P. Pharmacokinetic behavior of theophylline following PEEP in critically ill patients with acute lung injury. Iranian J. Pharm. Res. (2004) 3: 35-40.
18. Najafi A, Shariat Moharreri R, Mojtahedzadeh M, Khajavi MR, Hadavand N and Sadray S. The effect of PEEP on pharmacokinetic behavior of aminophylline in patients with acute lung injury. J. Iran. Soc. Anasthesiol. (2004) 24: 26-33.
19. Boucher BA, Wood GC and Swanson JM. Pharmacokinetic changes in criticall illness. Crit. Care Clin. (2006) 22: 255-271.
20. Vree TB, Shimoda M, Driessen JJ, Guelen JM, Janssen TJ, Termond EFS, Van Dalen R, Hafkenscheid JCM and Dirksen MSC. Decreased plasma albumin concentration results in increase volume of distribution and decreased elimination of midazolam in intensive care patients. Clin. Pharmacol. Ther. (1989) 46: 537-544.
21. Lamblin V, Favory R, Boulo M and Mathieu D. Microcirculatory alterations induced by sedation in intensive care patients, effects of midazolam alone and in association with sufentanil. Crit. Care. (2006) 10: R176.
22. Mcgrane S and Pandharipande PP. Sedation in the intensive care unit. Minerva. Anestesiol. (2010) 76: 697-704.